Special Offer: Get 50% off your first 2 months when you do one of the following
Personalized offer codes will be given in each session
Share This Webinar
About This Webinar
Terumo BCT, a global leader in blood component, therapeutic apheresis and cellular therapy technologies, believes in the potential of blood and cells to do even more for patients than they do today.
Terumo BCT’s Cell Therapy Technologies business enables researchers, developers and manufacturers to create next-generation cell and gene therapies.
Learn more at terumobct.com/cell-therapy.
Language:
English
Who can attend? Everyone
Featured Presenters
Regional Marketing Manager, Cell and Gene Therapy
Wenyan Leong, Ph.D. leads the North America market strategy for the Cell Therapy Technologies (CTT) portfolio of Terumo BCT. Prior to joining the marketing team, she spent 4 years as a CTT Field Applications Scientist in Asia Pacific, gaining a deep understanding of Cell and Gene Therapy manufacturing and commercialization. She seeks active dialogue and collaboration with cell and gene therapy developers to advance the research and development of novel therapies.
Wenyan holds a Ph.D. (Bioengineering), specializing in tissue engineering, from Nanyang Technological University, Singapore.
Wenyan holds a Ph.D. (Bioengineering), specializing in tissue engineering, from Nanyang Technological University, Singapore.
Blood & Cell Manufacturing Account Manager
Account manager lucky enough to cover the beautiful Pacific Northwest from California to Alaska. Rafal brings a decade of knowledge working in the hospital, blood bank and laboratory sciences space.
Field Application Scientist
Biologist with a passion for Neuroscience, Cell and Gene therapies. My education and experience is grounded in neurological disorders, specifically my interest areas are cellular therapies and the application of viral vectors for unmet medical needs.
Stuart holds a Ph.D. (Molecular Neuroscience), from Cambridge University, England.
Stuart holds a Ph.D. (Molecular Neuroscience), from Cambridge University, England.
Hosted By
The full session archive, available exclusively for attendees of the American Society of Gene & Cell Therapy's 23rd Annual Meeting, May 12-15, 2020.
Documents